Early-onset group B streptococcal disease in the United States: Potential for further reduction

Obstetrics and Gynecology

Volumn 123, Issue 4, 2014, Pages 828-837

  Verani, Jennifer R ^a   Spina, Nancy L ^a   Lynfield, Ruth ^a   Schaffner, William ^a   Harrison, Lee H ^a   Holst, Amy ^a   Thomas, Stepy ^a   Garcia, Jessica M ^a   Scherzinger, Karen ^a   Aragon, Deborah ^a   Petit, Susan ^a   Thompson, Jamie ^a   Pasutti, Lauren ^a   Carey, Roberta ^a   McGee, Lesley ^a   Weston, Emily ^a   Schrag, Stephanie J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIURIA; CASE STUDY; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC PROCEDURE; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; LABOR; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEWBORN; PRACTICE GUIDELINE; PREMATURITY; PRENATAL CARE; PRENATAL PERIOD; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

AGE OF ONSET; ANTIBIOTIC PROPHYLAXIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TERM BIRTH; UNITED STATES;

EID: 84898763628     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000163     Document Type: Article

References (22)

1. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36.
2. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, group B streptococcus, 2008. 2009. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/ gbs08.html. Retrieved May 6, 2013.
3. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, group B streptococcus, 2009. 2010. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/ gbs09.html. Retrieved May 6, 2013.
4. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, group B streptococcus, 2010. 2011. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/ gbs10.html. Retrieved May 6, 2013.
5. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, group B streptococcus, 2011. 2012. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/ gbs11.html. Retrieved May 6, 2013.
6. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11:497-513.
7. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
8. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
9. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360: 2626-36.
10. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent earlyonset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
11. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-5.
12. Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 2013;121:570-7.
13. Allegaert K, van Mieghem T, Verbesselt R, de Hoon J, Rayyan M, Devlieger R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 2009;200:170.e1-7.
14. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056-65.
15. Daniels JP, Gray J, Pattison HM, Gray R, Hills RK, Khan KS, et al; GBS Collaborative Group. Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. BJOG 2011;118:257-65.
16. de Tejada BM, Pfister RE, Renzi G, Francois P, Irion O, Boulvain M, et al. Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis. Clin Microbiol Infect 2011;17:1786-91.
17. Alfa MJ, Sepehri S, De Gagne P, Helawa M, Sandhu G, Harding GK. Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus. J Clin Microbiol 2010;48:3095-9.
18. Edwards RK, Novak-Weekley SM, Koty PP, Davis T, Leeds LJ, Jordan JA. Rapid group B streptococci screening using a realtime polymerase chain reaction assay. Obstet Gynecol 2008; 111:1335-41.
19. Honest H, Sharma S, Khan KS. Rapid tests for group B Streptococcus colonization in laboring women: a systematic review. Pediatrics 2006;117:1055-66.
20. Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccines 2008;4:444-8.
21. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early-and late-onset invasive disease in young-infants. Vaccine 2013;31(suppl 4):D52-7.
22. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al; Active Bacterial Core Surveillance (ABSs)/Emerging Infections Program Network, CDC. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057-64.